American Radiolabeled Chemicals (India) Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 5.15%
(FY 2023)
- Profit 3.61%
(FY 2023)
- Ebitda 330.98%
(FY 2023)
- Net Worth 10.34%
(FY 2023)
- Total Assets 0.51%
(FY 2023)
About American Radiolabeled Chemicals (India) Company
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Surendra Gupta and Ajay Gupta serve as directors at the Company.
- CIN/LLPIN
U24100TG2008PTC058742
- Company No.
058742
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at American Radiolabeled Chemicals (India) Company?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Gupta  | Director | 21-Apr-2008 | Current |
Ajay Gupta  | Director | 21-Apr-2008 | Current |
Financial Performance of American Radiolabeled Chemicals (India) Company.
American Radiolabeled Chemicals (India) Company Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.15% increase. The company also saw a slight improvement in profitability, with a 3.61% increase in profit. The company's net worth Soared by an impressive increase of 10.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of American Radiolabeled Chemicals (India) Company?
Unlock access to American Radiolabeled Chemicals (India) Company's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at American Radiolabeled Chemicals (India) Company?
Unlock and access historical data on people associated with American Radiolabeled Chemicals (India) Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of American Radiolabeled Chemicals (India) Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped American Radiolabeled Chemicals (India) Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
